Assessment of Covid-19 fear, anxiety and quality of life in chronic renal patients
COVID-19; Chronic kidney disease; Fear; Anxiety; Quality of life;
Introduction: COVID-19, a disease caused by Sars-Cov-2 or new Coronavirus since its appearance in Wuhan (China), has aroused fear and apprehension on a global scale due to its rapid spread. The consequences caused by the new Coronavirus were mainly sanitary and psychological, with a cluster of cases of depression, anxiety and domestic violence. Studies conducted in China early in the pandemic identified chronic kidney disease as a risk factor for worsening the disease and mortality in COVID-19 infected patients. Objectives: To evaluate the fear of COVID-19, anxiety and quality of life in the study participants with chronic dialysis and non-dialysis patients. In addition to characterizing the socioeconomic, demographic and clinical profile of the population studied, patients according to the scale of fear and anxious trait, measure anxious trait and fear with clinical and laboratory data and associate quality of life and anxiety disorder in chronic renal patients. Methodology: The research is a cross-sectional study that is being conducted through the application of questionnaires, including the quality of life scale with SF-36 instrument, the State Trait Anxiety Inventory (STAI) and the COVID-19 fear scale. The study is being conducted in chronic renal participants treated at conservative treatment outpatient clinics for chronic kidney disease treated at the Nephrology outpatient clinic of the Prof. Alberto Antunes University Hospital (HUPAA/UFAL). Results: To date, 47 chronic renal patients have been approached, all non-dialysis. Being 22 males and 25 females. The mean age of the participants ranged from 18 to 97 years of age, and most are over 60 years of age. More than 50% of the sample is brown, living in Maceió, has a partner (a) and took the vaccine for COVID-19. The other questionnaires have not yet been analyzed for the scores. Conclusion: With the research it is expected to know whether the fear of COVID-19 decreased in chronic renal patients after vaccination, whether dialysis has higher levels of anxiety than those on conservative treatment and whether the fear of COVID-19 is higher in more inflamed chronic renal.